Suppr超能文献

新冠病毒(SARS-CoV-2)微生物学诊断中流行率和预测试概率的重要性:西班牙 2020 年的案例。

The importance of prevalence and pre-test probability on the microbiological diagnosis of SARS-CoV-2: the case of Spain in 2020.

机构信息

Dr. Andrés Canut-Blasco. Servicio de Microbiología. Hospital Universitario Araba. C/Francisco Leandro de Viana s/n. 01009 Vitoria-Gasteiz, Spain.

出版信息

Rev Esp Quimioter. 2023 Oct;36(5):498-506. doi: 10.37201/req/033.2023. Epub 2023 Jul 21.

Abstract

OBJECTIVE

The aim of this work was to estimate the conditioned probability for the diagnosis of SARS-CoV-2 infection with reverse transcription polymerase chain reaction (RT-PCR), viral antigen rapid diagnostic tests (Ag-RDT), and antibody detection tests depending on the prevalence in the specific healthcare settings in Spain in 2020, and on the pre-test probability (PTP) according to the clinical situation, age and unknown or close contacts of the patient.

METHODS

Performance parameters of tests were obtained from literature. Prevalence data and PTP were obtained from Spanish sources and a survey, respectively. The post-test probability is the positive predictive value (PPV) when test is positive. For negative result, we also calculated the probability of having the infection (false negatives).

RESULTS

For both RT-PCR and viral Ag-RDT, the lowest PPV values were for the population screenings. This strategy proved to be useful in ruling out infection but generates a high number of false positives. At individual level, both tools provided high PPV (≥ 97%) when the PTP values are over 35%. In seroprevalence studies, though the specificity of IgG alone tests is high, under low seroprevalence, false positives cannot be avoided. Total antibodies tests are useful for diagnosis of COVID-19 in those doubtful cases with RT-PCR or Ag-RDT tests being repeatedly negative.

CONCLUSIONS

The interpretating of results depends not only on the accuracy of the test, but also on the prevalence of the infection in different settings, and the PTP associated to the patient before performing the test.

摘要

目的

本研究旨在根据西班牙 2020 年特定医疗环境中的流行率和根据临床情况、年龄以及患者的未知或密切接触者确定的预测试概率(PTP),估计使用逆转录聚合酶链反应(RT-PCR)、病毒抗原快速诊断检测(Ag-RDT)和抗体检测诊断 SARS-CoV-2 感染的条件概率。

方法

从文献中获得了检测的性能参数。流行率数据和 PTP 分别从西班牙来源和一项调查中获得。后验概率是检测阳性时的阳性预测值(PPV)。对于阴性结果,我们还计算了感染的概率(假阴性)。

结果

对于 RT-PCR 和病毒 Ag-RDT,人群筛查的最低 PPV 值。这种策略在排除感染方面非常有用,但会产生大量假阳性。在个体层面,当 PTP 值超过 35%时,两种工具都提供了较高的 PPV(≥97%)。在血清流行率研究中,尽管单独 IgG 测试的特异性较高,但在低血清流行率下,仍无法避免假阳性。对于 RT-PCR 或 Ag-RDT 检测反复阴性的可疑病例,总抗体检测对于 COVID-19 的诊断非常有用。

结论

结果的解释不仅取决于测试的准确性,还取决于不同环境中感染的流行率以及在进行测试前与患者相关的 PTP。

相似文献

1
The importance of prevalence and pre-test probability on the microbiological diagnosis of SARS-CoV-2: the case of Spain in 2020.
Rev Esp Quimioter. 2023 Oct;36(5):498-506. doi: 10.37201/req/033.2023. Epub 2023 Jul 21.
2
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
4
Sars-Cov-2 Infection Screening Using Two Serological Testing Methods.
Niger J Physiol Sci. 2020 Dec 31;35(2):117-121.
5
[Evaluation of two COVID-19 antigenic diagnostic tests: and compared to ].
Pan Afr Med J. 2021 Aug 6;39:228. doi: 10.11604/pamj.2021.39.228.30752. eCollection 2021.
8
Evaluation of the Abbott Panbio™ COVID-19 antigen detection rapid diagnostic test among healthcare workers in elderly care.
PLoS One. 2023 Feb 24;18(2):e0276244. doi: 10.1371/journal.pone.0276244. eCollection 2023.
9
Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test.
Eur J Clin Invest. 2020 Oct;50(10):e13357. doi: 10.1111/eci.13357. Epub 2020 Aug 11.
10
[Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability].
Rev Esp Quimioter. 2020 Dec;33(6):410-414. doi: 10.37201/req/080.2020. Epub 2020 Sep 11.

本文引用的文献

1
Tale of the Titers: Serologic Testing for SARS-CoV-2-Yes, No, and Maybe, With Clinical Examples From the IDSA Diagnostics Committee.
Open Forum Infect Dis. 2022 Dec 14;10(1):ofac674. doi: 10.1093/ofid/ofac674. eCollection 2023 Jan.
2
Nucleic acid testing of SARS-CoV-2: A review of current methods, challenges, and prospects.
Front Microbiol. 2022 Dec 9;13:1074289. doi: 10.3389/fmicb.2022.1074289. eCollection 2022.
3
Antibody tests for identification of current and past infection with SARS-CoV-2.
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
5
Real World Performance of SARS-CoV-2 Antigen Rapid Diagnostic Tests in Various Clinical Settings.
Infect Control Hosp Epidemiol. 2022 Mar 2:1-20. doi: 10.1017/ice.2022.3.
7
Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2.
Int J Environ Res Public Health. 2021 Apr 27;18(9):4640. doi: 10.3390/ijerph18094640.
8
Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis.
Lancet Infect Dis. 2021 Sep;21(9):1233-1245. doi: 10.1016/S1473-3099(21)00146-8. Epub 2021 Apr 12.
9
Perfect as the enemy of good: tracing transmissions with low-sensitivity tests to mitigate SARS-CoV-2 outbreaks.
Lancet Microbe. 2021 May;2(5):e219-e224. doi: 10.1016/S2666-5247(21)00004-5. Epub 2021 Mar 12.
10
COVID-19 antibody seroprevalence in Santa Clara County, California.
Int J Epidemiol. 2021 May 17;50(2):410-419. doi: 10.1093/ije/dyab010.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验